Highlights
A comprehensive pooled analysis of four major INTERACT trials involving 11,312 patients confirms that intensive systolic blood pressure (SBP) lowering to a target of less than 140 mmHg is safe and significantly improves functional outcomes in acute intracerebral hemorrhage (ICH).
Key findings indicate that the efficacy of intensive BP lowering is highly time-dependent, with the greatest benefits for functional recovery and the prevention of hematoma expansion occurring when treatment is initiated within 3 hours of symptom onset.
